Live feed
Filing
SC 13D/A
SC 13D/A0000903423-17-000564·GSK plc
Schedule 13D ownership disclosure
HTG MOLECULAR DIAGNOSTICS, INC
Security class unavailable · CUSIP: 40434H104
Event date: 2017-08-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 792,781
- Percent of class
- 6.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-17-000564
- Form type
- SC 13D/A
- Filer
- GSK plc
- CIK
- CIK 1131399
- Filed
- Sep 01, 2017
- Reporting period
- Aug 04, 2017
- Description
- Schedule 13D beneficial ownership